Direct-Acting Oral Anticoagulants ClotChip Device Stud

I'm Interested!

ClotChip for monitoring Direct-Acting Oral Anticoagulants (DOACs) in Children.

Sex at Birth: Any
Age: Child (Birth - 17)
Accepting Healthy People: No
Type: Observational
Trial Phase: NA
Conditions Being Studied: Hemophilia

Study Purpose

The purpose of this study is to test this device called ClotChip on patients taking anti-coagulation therapy. This device can accurately measure blood levels of patients with certain bleeding disorders at the bedside using only a drop of blood taken by pricking the finger.

Principal Investigator
Sanjay Ahuja MD

Department/Division
Pediatrics (Hematology/Oncology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20220527
StudyID: 2022-0969
ClinicalTrials.gov: N/A

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422